TB
Theravance Biopharma, Inc. (TBPH)
NASDAQ·Healthcare·Biotechnology
$16.77
-0.24%
Mkt Cap $847.57M
Analyst Ratings
Buy
7
Hold
3
Sell
0
Price Target (7 analysts)
$27.00
Range $14.00 – $40.00
Implied Upside
+61.0%
Consensus $27.00 vs current $16.77
NASDAQ·Healthcare·Biotechnology
$16.77
-0.24%
Mkt Cap $847.57M
Buy
7
Hold
3
Sell
0
Price Target (7 analysts)
$27.00
Range $14.00 – $40.00
+61.0%
Consensus $27.00 vs current $16.77